Literature DB >> 25511661

Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer.

M Ahmed1, A D Purushotham, K Horgan, J M Klaase, M Douek.   

Abstract

BACKGROUND: Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in early breast cancer. Currently, no consensus exists on the optimal site of injection of the radioactive tracer or blue dye.
METHODS: A systematic review and meta-analysis of studies comparing superficial and deep injections of radioactive tracer or blue dye for lymphatic mapping and SLNB was performed. The axillary and extra-axillary sentinel lymph node (SLN) identification rates obtained by lymphoscintigraphy and intraoperative SLNB were evaluated. Pooled odds ratios (ORs) and 95 per cent c.i. were estimated using fixed-effect analyses, or random-effects analyses if there was statistically significant heterogeneity (P < 0·050).
RESULTS: Thirteen studies were included in the meta-analysis. There was no significant difference between superficial and deep injections of radioactive tracer for axillary SLN identification on lymphoscintigraphy (OR 1·59, 95 per cent c.i. 0·79 to 3·17), during surgery (OR 1·27, 0·60 to 2·68) and for SLN identification using blue dye (OR 1·40, 0·83 to 2·35). The rate of extra-axillary SLN identification was significantly greater when deep rather than superficial injection was used (OR 3·00, 1·92 to 4·67). The discordance rate between superficial and deep injections ranged from 4 to 73 per cent for axillary and from 0 to 61 per cent for internal mammary node mapping.
CONCLUSION: Both superficial and deep injections of radioactive tracer and blue dye are effective for axillary SLN identification. Clinical consequences of discordance rates between the two injection techniques are unclear. Deep injections are associated with significantly greater extra-axillary SLN identification; however, this may not have a significant impact on clinical management.
© 2014 BJS Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25511661     DOI: 10.1002/bjs.9673

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  17 in total

1.  A Novel Indocyanine Green Fluorescence-Guided Video-Assisted Technique for Sentinel Node Biopsy in Breast Cancer.

Authors:  Luca Sorrentino; Alessandra Sartani; Gaia Pietropaolo; Daniela Bossi; Serena Mazzucchelli; Marta Truffi; Diego Foschi; Fabio Corsi
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

2.  How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.

Authors:  Anita Mamtani; Andrea V Barrio; Tari A King; Kimberly J Van Zee; George Plitas; Melissa Pilewskie; Mahmoud El-Tamer; Mary L Gemignani; Alexandra S Heerdt; Lisa M Sclafani; Virgilio Sacchini; Hiram S Cody; Sujata Patil; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2016-05-09       Impact factor: 5.344

3.  Quantum dot-NanoLuc bioluminescence resonance energy transfer enables tumor imaging and lymph node mapping in vivo.

Authors:  Anyanee Kamkaew; Haiyan Sun; Christopher G England; Liang Cheng; Zhuang Liu; Weibo Cai
Journal:  Chem Commun (Camb)       Date:  2016-05-19       Impact factor: 6.222

4.  Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate.

Authors:  Samine Sahbai; Florin-Andrei Taran; Annette Staebler; Diethelm Wallwiener; Christian la Fougère; Sara Brucker; Helmut Dittmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-03       Impact factor: 9.236

5.  In Vivo Sentinel Lymph Node Detection with Indocyanine Green in Colorectal Cancer.

Authors:  Daniel Staniloaie; Constantin Budin; Alexandru Ilco; Danut Vasile; Amalia Loredana Calinoiu; Adina Rusu; George Iancu; Tarek Ammar; Cristian Florin Georgescu; Maria-Daniela Tanasescu; Alexandru Minca; Dragos Eugen Georgescu
Journal:  Maedica (Bucur)       Date:  2022-06

Review 6.  Current Management of the Axilla.

Authors:  Damian McCARTAN; Mary L Gemignani
Journal:  Clin Obstet Gynecol       Date:  2016-12       Impact factor: 2.190

7.  Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.

Authors:  Ted A James; Alex R Coffman; Anees B Chagpar; Judy C Boughey; V Suzanne Klimberg; Monica Morrow; Armando E Giuliano; Seth P Harlow
Journal:  Ann Surg Oncol       Date:  2016-07-21       Impact factor: 5.344

8.  Is blue dye still required during sentinel lymph node biopsy for breast cancer?

Authors:  Mirjam Cl Peek; Tibor Kovacs; Rose Baker; Hisham Hamed; Ash Kothari; Michael Douek
Journal:  Ecancermedicalscience       Date:  2016-09-19

Review 9.  The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic review.

Authors:  Pei-Sheng He; Feng Li; Guan-Hua Li; Can Guo; Tian-Jin Chen
Journal:  BMC Cancer       Date:  2016-02-16       Impact factor: 4.430

10.  Precise intraoperative sentinel lymph node biopsies guided by lymphatic drainage in breast cancer.

Authors:  Xiaoyan Li; Sisi Chen; Liyu Jiang; Xiaoli Kong; Tingting Ma; Hong Xu; Qifeng Yang
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.